Clik here to view.
Penn Medicine Researchers Unlock the Door to Tumor Microenvironment for CAR T...
In a new study published online today in Nature Cancer, Penn Medicine researchers found that combining chimeric antigen receptor (CAR) T cell therapy with a PAK4 inhibitor drug allowed the engineered...
View ArticleClik here to view.
Penn Medicine at the 62nd American Society of Hematology Annual Meeting and...
Experts from the Perelman School of Medicine at the University of Pennsylvania will be presenting data on the latest advances in cancer research and treatment at ASH’s annual meeting from December 5-8.
View ArticleClik here to view.
Penn Medicine Researchers Chart a Path Forward with Unifying Definition of...
Two Penn Medicine researchers have developed a unifying definition of “cytokine storm” to provide physicians with a framework to assess and treat severely-ill patients whose immune systems have gone...
View ArticleClik here to view.
Penn’s Basser Center for BRCA Awards 2020 Basser Global Prize to Bella...
Kaufman is the director of the Breast Oncology Institute, as well as the president of Sheba Comprehensive Cancer Center at the Sheba Medical Center.
View ArticleClik here to view.
Penn Geriatrician Lisa Walke, MD, Named to 2021 Carol Emmott Fellowship Class
Lisa Walke, MD, chief of Geriatric Medicine in the Perelman School of Medicine at the University of Pennsylvania, has been selected for the 2021 Carol Emmott Fellowship class.
View ArticleClik here to view.
Off-the-Shelf Immune Drug Shows Promise in Aggressive Multiple Myeloma
Of 22 patients treated with the injection dose of teclistamab, who were also chosen for the phase II study, 74 percent experienced a partial response or better.
View ArticleClik here to view.
New Biomarker Identifies Patients with Aggressive Lymphoma Who Don’t Respond...
A new biomarker discovered by a team that includes researchers from Penn Medicine identifies patients with an aggressive form of lymphoma unlikely to respond to the targeted treatment ibrutinib.
View ArticleClik here to view.
Penn Medicine Researchers Receive Two Major NIH Grants for Studies of Genome...
The initiative, known as the 4D Nucleome Program, broadly aims to map higher-order genome structures across space and time, as well as to understand how the twists and loops of the DNA sequence govern...
View ArticleClik here to view.
CRISPR-edited CAR T Cells Enhance Fight Against Blood Cancers
Knocking out a protein known to stifle T cell activation on CAR T cells using the CRISPR/Cas9 technology enhanced the engineered T cells’ ability to eliminate blood cancers, according to new...
View ArticleClik here to view.
Study Shows 329 People are Injured by Firearms in U.S. Each Day, But for...
new study by a team of researchers in the Perelman School of Medicine at the University of Pennsylvania and Columbia University’s Mailman School of Public Health expands research on trends of fatal and...
View ArticleClik here to view.
Study Finds No Change in Preterm Birth or Stillbirth in Philadelphia During...
The findings, published today in JAMA, resulted from the examination of an ongoing, racially-diverse pregnancy cohort that assesses both spontaneous and medically-indicated preterm birth.
View ArticleClik here to view.
Penn Medicine mRNA Vaccine Technology Pioneer and Health Policy Experts Join...
In conjunction with the FDA’s EUA Advisory Committee meetings to be held Dec. 10 for the Pfizer / BioNTech COVID-19 vaccine and Dec. 17 for the Moderna COVID-19 vaccine, Penn Medicine will host a...
View ArticleClik here to view.
Discovery Upends Traditional View of “Killer T Cells’” Travels in the Body
Immune cells called “killer T cells,” also known as cytotoxic or cytolytic CD8 T cells, normally stay in the bloodstream and do not enter organs and other tissues, according to a new study from...
View ArticleClik here to view.
Neuroanesthesia Expert Deborah J. Culley, MD, Named New Chair of...
Deborah J. Culley, MD, a neuroanesthesiologist and nationally recognized leader in geriatric anesthesia, has been named chair of the department of Anesthesiology and Critical Care at Penn Medicine....
View ArticleClik here to view.
Fewer Than 2 Percent of OB-GYN Doctors Can Prescribe Life-Saving Opioid...
The number of obstetrician-gynecologists who are able to prescribe a lifesaving opioid addiction medicine called buprenorphine to their patients is woefully small, comprising less than two percent of...
View ArticleClik here to view.
Scientists Unveil a Promising New Strategy For Combating Pancreatic Cancer
A DNA mutation that occurs frequently in the development of many pancreatic tumors appears to make these cancers vulnerable to an existing type of drug known as PARP inhibitors, according to a new...
View ArticleClik here to view.
Penn Medicine Researchers Receive $4.8 Million Pilot Grant to Study Genetics...
A team of researchers led by Li-San Wang, PhD, Professor of Pathology and Laboratory Medicine in the Perelman School of Medicine at the University of Pennsylvania, has been awarded a two-year pilot...
View ArticleClik here to view.
Penn Presbyterian Medical Center CEO Michele M. Volpe Named New Chair of the...
Michele M. Volpe, FACHE, chief executive officer of Penn Presbyterian Medical Center, has been named the new chair of the Hospital and Healthsystem Association of Pennsylvania’s Board of Directors. She...
View ArticleClik here to view.
Too Many Donor Kidneys Are Discarded in U.S. Before Transplantation
When kidneys are removed from deceased organ donors in the United States, they are often subjected to “procurement biopsies” and are discarded if certain abnormalities are seen in the kidney tissue — a...
View ArticleClik here to view.
Monitoring Patients Remotely Leads to a Fourfold Decline in Returns to...
Researchers saw a fourfold decline in the rate of patients who needed to go back to the hospital after total hip or knee replacements if they were enrolled in a program that used wearable step counters...
View Article